Novo Integrated Sciences, Inc. · OTC:NVOS

Novo Integrated Sciences, Inc. financial statements

Novo Integrated Sciences, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2017FY2016
Revenue13.3M12.6M11.7M9.31M7.86M9.42M8.89M7.96M7.18M7.47M
Cost of revenue7.55M7.62M6.94M5.48M4.80M5.90M5.47M4.99M4.67M4.76M
Gross profit5.74M4.95M4.80M3.82M3.06M3.52M3.42M2.98M2.51M2.71M
Research and development000
Selling, general and administrative14.0M13.5M14.4M8.09M7.29M4.02M4.88M3.03M2.39M2.93M
Operating income-8.31M-8.55M-25.0M-4.27M-4.26M-785.6K-1.57M-164.9K122.0K-401.6K
Depreciation and amortization2.26M2.30M3.02M1.72M1.45M97.1K73.4K67.8K72.6K1.01K
EBITDA-6.05M-6.25M-22.0M-2.55M-2.82M-688.5K-1.50M-97.1K194.5K-400.6K
Interest expense652.4K5.12M1.59M165.0K156.7K222.2K564.5K554.7K0523.3K
Income before tax-16.1M-13.3M-33.1M-4.47M-4.92M-403.6K-2.12M-164.9K-346.2K-2.77M
Income tax-22.3K22.3K178.1K-46.4K282.6K7.52K111.7K02.40M
Net income-16.1M-13.2M-33.0M-4.46M-4.92M-392.0K-2.11M-164.9K-340.5K-2.77M
Earnings per share, basic-0.89-1.30-1.13-1.80-2.13-0.18-1.02-0.09-13.29

Balance sheet

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2017FY2016
Cash and equivalents844.6K416.3K12.7M8.29M2.07M2.08M675.7K1.90M110.3K14.1K
Short-term investments000
Receivables3.15M1.47M6.38M2.28M2.04M1.76M1.73M1.50M2.31M1.19M
Inventory1.00M1.11M645.1K339.4K157.4K-785.8K1
Current assets5.41M4.39M20.1M11.1M4.29M4.10M2.57M3.65M2.57M14.1K
Property, plant and equipment8.61M3.16M3.41M400.3K303.0K318.7K318.7K
Goodwill6.55M7.58M11.4M9.49M636.9K623.1K604.1K399.4K0
Total assets32.1M35.6M71.8M62.0M35.4M32.3M4.74M5.51M2.89M27.9K
Accounts payable3.24M3.51M1.62M1.45M883.8K1.14M1.31M1.70M4.94M13.1K
Current liabilities14.6M7.90M12.7M8.46M2.60M3.03M3.35M4.27M9.97M13.1K
Long-term debt65.0K1.11M6.12M952.1K1.20M1.22M5.53M11.6K11.6K
Total debt4.71M4.47M19.8M13.7M4.39M5.13M1.61M5.54M6.33M
Total liabilities17.5M11.1M27.4M18.2M5.82M6.73M4.57M9.80M9.97M13.1K
Shareholders' equity14.9M24.8M44.4M43.9M29.6M25.6M201.4K-4.27M-7.08M14.8K
Shares outstanding18.0M10.2M29.1M2.48M2.30M2.17M2.08M1.78M208.5K

Cash flow

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2017FY2016
Cash from operations-2.24M-2.24M-5.88M-1.02M-441.7K-822.3K-934.5K-810.7K101.4K-175.6K
Capital spending-49.2K-49.2K-190.2K-255.9K-12.1K-107.6K-178.6K-38.2K-55.0K-113.9K
Free cash flow-2.29M-2.29M-6.07M-1.28M-453.8K-929.9K-1.11M-848.9K46.4K-289.5K
Cash from investing-49.2K-49.2K3.00M657.1K-842.9K-217.2K-749.5K-462.3K-113.9K
Cash from financing763.9K763.9K-427.1K4.32M-271.7K3.07M-11.6K3.11M402.2K187.9K
Dividends paid000
Share buybacks0-62.5K150.0K150.0K
Change in cash-1.76M-1.76M-6.11M6.23M-15.9K1.41M-1.22M1.79M42.2K12.3K